AgenTus Therapeutics SA
Ouverture de faillite 0.6 FTEAgenTus Therapeutics reported total assets of €4.55m at the end of the 2018 financial year (annual accounts filed with the NBB on 31 Jan 2020), with 0.6 full-time equivalent.
The score of AgenTus Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2018
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AgenTus Therapeutics's annual accounts
| 2018 | |
|---|---|
| Net result | −527,254 € |
| Equity | −462,254 € |
| Cash | €3.21m |
| Total assets | €4.55m |
Filed annual accounts
- Year ended 31 Dec 2018filed on 31 Jan 2020
AgenTus Therapeutics's financial analysis
- Solvency-10.2%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AgenTus Therapeutics
AgenTus Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0702.962.265
- VAT number
- BE0702962265
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 10 Sep 2018
- Registered office
- 1410 Waterloo
- Size
- Micro · 0.6 FTE
- Latest accounts
- 2018 · filed on 31 Jan 2020
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
AgenTus Therapeutics (SA) has been based in Waterloo since 2018, active in: research and experimental development on other natural sciences and engineering. For 2018, it reports a net loss of 527,254 € and equity of −462,254 €; its revenue is not published. With 0.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -10.2%, below the median of its sector (58.2%).
Companies similar to AgenTus Therapeutics
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Celyad Oncology Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €4.03m
- HepaVue Dx Research and experimental development on natural sciences and engineering Waterloo · balance sheet €3.71m
- WEL Research Institute Research and experimental development on natural sciences and engineering Wavre · balance sheet €3.61m
- BiocSol Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €5.75m
- Academic Medical Interdisciplinary Research Foundation - Recherche Academique Medicale Interdisciplinaire Foundation Research and experimental development on natural sciences and engineering Lasne · balance sheet €5.87m
- BioSenic Research and experimental development on natural sciences and engineering Tubize · balance sheet €3.40m
- Innovation Facilities Research and experimental development on natural sciences and engineering Nivelles · balance sheet €3.30m
- Parexel Belgium Research and experimental development on natural sciences and engineering Wavre · balance sheet €6.82m
Frequently asked questions about AgenTus Therapeutics
What is the revenue of AgenTus Therapeutics?
AgenTus Therapeutics files its accounts in a format where revenue is optional: it is not published for 2018.
What is the VAT number of AgenTus Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0702962265 for AgenTus Therapeutics, if the company is VAT-registered. Its company number (CBE) is 0702.962.265.
Where is the registered office of AgenTus Therapeutics?
According to the CBE register, the registered office of AgenTus Therapeutics is in 1410 Waterloo.
What is the equity of AgenTus Therapeutics?
At the close of the 2018 financial year, the equity of AgenTus Therapeutics amounts to -462,254 €, a solvency of -10.2% of total assets.
How many people work at AgenTus Therapeutics?
0.6 full-time equivalents on average according to the 2018 social balance sheet.
Who manages AgenTus Therapeutics?
The register lists 5 active mandates at AgenTus Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AgenTus Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →